TCL Archive Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials. December 2, 2005
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004